Dissociation of intracellular signaling pathways in response to partial agonist ligands of the T cell receptor

被引:78
作者
Chau, LA
Bluestone, JA
Madrenas, J
机构
[1] John P Robarts Res Inst, Transplantat & Immunobiol Grp, London, ON N6A 5K8, Canada
[2] Univ Western Ontario, Dept Microbiol & Immunol, London, ON N6A 5K8, Canada
[3] Univ Western Ontario, Dept Med, London, ON N6A 5K8, Canada
[4] Univ Chicago, Ben May Inst Canc Res, Comm Immunol, Chicago, IL 60615 USA
关键词
T cell receptor; partial agonist; signal transduction; mitogen-activated protein kinases; p120-GAP;
D O I
10.1084/jem.187.10.1699
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The T cell receptor (TCR) is a versatile receptor able to generate different signals that result in distinct T cell responses. The pattern of early signals is determined by the TCR binding kinetics that control the ability of the ligand to coengage TCR and coreceptor. Coengagement of TCR and CD4 results in an agonist signaling pattern with complete tyrosine phosphorylation of TCR subunits, and recruitment and activation of ZAP-70. In contrast, TCR engagement without CD4 coengagement causes a partial agonist type of signaling, characterized by distinct phosphorylation of TCR subunits and recruitment but no activation of ZAP-70. The pathways triggered by partial agonist signaling are unknown. Here, we show that agonists cause association of active lck and active ZAP-70 with p120-GTPase-activating protein (p120-GAP). These associations follow engagement of CD4 or CD3, respectively. In contrast, partial agonists do not activate lck or ZAP-70, but induce association of p120-GAP with inactive ZAP-70. Despite these differences, both agonist and partial agonist signals activate the mitogen-activated protein kinase (MAPK) pathway. However, MAPK activation by partial agonists is transient, supporting a kinetic, CD4-dependent model for the mechanism of action of variant TCR ligands. Transient MAPK activation may explain some of the responses to TCR partial agonists and antagonists.
引用
收藏
页码:1699 / 1709
页数:11
相关论文
共 82 条
[41]  
Madrenas J, 1996, Semin Immunol, V8, P83, DOI 10.1006/smim.1996.0011
[42]   The efficiency of CD4 recruitment to ligand-engaged TCR controls the agonist/partial agonist properties of peptide-MHC molecule ligands [J].
Madrenas, J ;
Chau, LA ;
Smith, J ;
Bluestone, JA ;
Germain, RN .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (02) :219-229
[43]   ZETA-PHOSPHORYLATION WITHOUT ZAP-70 ACTIVATION-INDUCED BY TCR ANTAGONISTS OR PARTIAL AGONISTS [J].
MADRENAS, J ;
WANGE, RL ;
WANG, JL ;
ISAKOV, N ;
SAMELSON, LE ;
GERMAIN, RN .
SCIENCE, 1995, 267 (5197) :515-518
[44]   Ras effectors [J].
Marshall, CJ .
CURRENT OPINION IN CELL BIOLOGY, 1996, 8 (02) :197-204
[45]   RAS TARGET PROTEINS IN EUKARYOTIC CELLS [J].
MARSHALL, MS .
FASEB JOURNAL, 1995, 9 (13) :1311-1318
[46]   MAGNITUDE OF RESPONSE OF HISTOCOMPATIBILITY-RESTRICTED T-CELL CLONES IS A FUNCTION OF THE PRODUCT OF THE CONCENTRATIONS OF ANTIGEN AND IA MOLECULES [J].
MATIS, LA ;
GLIMCHER, LH ;
PAUL, WE ;
SCHWARTZ, RH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1983, 80 (19) :6019-6023
[47]   PROFOUND BLOCK IN THYMOCYTE DEVELOPMENT IN MICE LACKING P56(LCK) [J].
MOLINA, TJ ;
KISHIHARA, K ;
SIDEROVSKI, DP ;
VANEWIJK, W ;
NARENDRAN, A ;
TIMMS, E ;
WAKEHAM, A ;
PAIGE, CJ ;
HARTMANN, KU ;
VEILLETTE, A ;
DAVIDSON, D ;
MAK, TW .
NATURE, 1992, 357 (6374) :161-164
[48]  
MORENO MB, 1995, CANCER IMMUNOL IMMUN, V40, P182, DOI 10.1007/s002620050161
[49]  
NEL AE, 1990, J IMMUNOL, V145, P971
[50]  
NEUMEISTER EN, 1995, MOL CELL BIOL, V15, P3171